Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Sumitomo Pharma to Raise Up to \116.4 Billion Through Public Offering
Sumitomo Pharma <4506> announced after the market close on the 8th that it will conduct a public offering. The company plans to issue 51,304,400 new shares domestically and internationally, with an over-allotment option of up to 7,695,600 additional shares subject to demand. The offering price will be determined on one of the days between the 20th and the 23rd. The total number of issued shares is expected to increase by up to 14.8%. Net proceeds of up to approximately \116.49 billion will be allocated to research and development, primarily to fund clinical trials for two oncology treatments ? "encorafenib" and "nuvercertib" ? as well as to repay interest-bearing debt.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
GameWith Draws Strong Investor Interest as Q3 Operating Profit Tops Full-Year Guidance
Tokyo Stocks Mixed at Open as U.S. Rally Is Offset by Middle East Uncertainty
Softechnix Opens With Buy Orders on First Day of Trading on TSE Standard Market
Singapore Nikkei 225 Futures Open at \56,825 on the 9th, Up \440
Tokyo Stocks Seen Extending Gains for Fifth Consecutive Day on Strong U.S. Rally; Middle East Developments in Focus
Market Outlook: AI and Semiconductor Stocks Surge While Construction Shares Rise
FX Outlook for Tomorrow: Will the Dollar Fall to the \157 Level?
GameWith Returns to Profit in June?February Period on Strong Media and E-Sports Segments
UOKI, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 50%
ALTECH, Dec-Feb (1Q) Net Income Turns to Loss